Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO.
asthma management
biomarkers
childhood
consensus
diagnosis
guidelines
therapy
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
revised:
22
03
2024
received:
05
02
2024
accepted:
25
03
2024
medline:
26
4
2024
pubmed:
26
4
2024
entrez:
26
4
2024
Statut:
ppublish
Résumé
Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even "real-time," monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design.
Substances chimiques
Anti-Asthmatic Agents
0
Types de publication
Journal Article
Review
Practice Guideline
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14129Subventions
Organisme : Respiratory Effectiveness Group
Investigateurs
Yuichi Adachi
(Y)
Eleni Anastasiou
(E)
Zeinab Awad El-Sayed
(ZA)
Héctor Badellino
(H)
Rasha H El-Owaidy
(RH)
Ivana Filipovic
(I)
Nikolaos Papadopoulos
(N)
Paulo Pitrez
(P)
César Pozo Beltrán
(CP)
Cristina Rivas
(C)
Alvaro Teijeiro
(A)
Su-Boon Yong
(SB)
Informations de copyright
© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
García‐Marcos L, Asher M, Pearce N, et al. The burden of asthma, hay fever and eczema in children in 25 countries: GAN phase I study. Eur Respir J. 2022;60(3):2102866.
Asher M, Rutter C, Bissell K, et al. Worldwide trends in the burden of asthma symptoms in school‐aged children: global asthma network phase I cross‐sectional study. Lancet (London, England). 2021;398(10311):1569‐1580.
Szefler S, Zeiger R, Haselkorn T, et al. Economic burden of impairment in children with severe or difficult‐to‐treat asthma. Ann Allergy Asthma Immunol. 2011;107(2):110‐9.e1.
Fleming M, Fitton C, Steiner M, et al. Educational and health outcomes of children treated for asthma: Scotland‐wide record linkage study of 683 716 children. Eur Respir J. 2019;54(3):1802309.
Serebrisky D, Wiznia A. Pediatric Asthma: A Global Epidemic. Ann Glob Health. 2019;85(1):6.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2023. https://ginasthma.org/2023‐gina‐main‐report/. Accessed May 2023.
Schatz M, Rachelefsky G, Krishnan J. Follow‐up after acute asthma episodes: what improves future outcomes? J Emerg Med. 2009;37(2 Suppl):S42‐S50.
Papadopoulos N, Mathioudakis A, Custovic A, et al. Current and optimal practices in childhood asthma monitoring among multiple international stakeholders. JAMA Netw Open. 2023;6(5):e2313120.
Voorend‐van Bergen S, Vaessen‐Verberne A, Brackel H, et al. Monitoring strategies in children with asthma: a randomised controlled trial. Thorax. 2015;70(6):543‐550.
Petsky H, Cates C, Kew K, Chang A. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta‐analysis. Thorax. 2018;73(12):1110‐1119.
Prabhakaran L, Chun WY. Effectiveness of the eCARE programme: a short message service for asthma monitoring. BMJ Health Care Inform. 2019;26(1):e100007.
Mathioudakis A, Custovic A, Deschildre A, et al. Research priorities in pediatric asthma: results of a global survey of multiple stakeholder groups by the pediatric asthma in real life (PeARL) think tank. J Allergy Clin Immunol Pract. 2020;8(6):1953‐60.e9.
Asthma: diagnosis, monitoring and chronic asthma management [Text]. National Institute for Health and Care Excellence (NICE). 2021. https://www.ncbi.nlm.nih.gov/books/NBK560178/. Accessed March 22, 2021.
BTS/SIGN British Guideline on the management of asthma 2019. https://www.brit‐thoracic.org.uk/news/2019/bts‐sign‐british‐guideline‐on‐the‐management‐of‐asthma‐2019/.
Australian Asthma Handbook. The National Guidelines for Health Professionals. 2022. https://www.asthmahandbook.org.au/
Cloutier M, Baptist A, Blake K, et al. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and prevention program coordinating committee expert panel working group. J Allergy Clin Immunol. 2020;146(6):1217‐1270.
Pamuk G, Le Bourgeois M, Abou Taam R, de Blic J, Delacourt C, Lezmi G. The economic burden of severe asthma in children: a comprehensive study. J Asthma. 2021;58(11):1467‐1477.
Ekström M, Nwaru B, Hasvold P, Wiklund F, Telg G, Janson C. Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden. Allergy. 2019;74(11):2181‐2190.
Fleming L, Murray C, Bansal A, et al. The burden of severe asthma in childhood and adolescence: results from the paediatric U‐BIOPRED cohorts. Eur Respir J. 2015;46(5):1322‐1333.
Ronco L, Folino A, Goia M, Crida B, Esposito I, Bignamini E. Do not forget asthma comorbidities in pediatric severe asthma! Front Pediatr. 2022;10:932366.
Lezmi G, Lejeune S, Pin I, et al. Factors associated with asthma severity in children: data from the French COBRAPed cohort. J Allergy Clin Immunol Pract. 2021;9(5):1969‐1979.
Jia CE, Zhang HP, Lv Y, et al. The asthma control test and asthma control questionnaire for assessing asthma control: systematic review and meta‐analysis. J Allergy Clin Immunol. 2013;131(3):695‐703.
van Dijk BCP, Svedsater H, Heddini A, Nelsen L, Balradj JS, Alleman C. Relationship between the asthma control test (ACT) and other outcomes: a targeted literature review. BMC Pulm Med. 2020;20(1):79.
Liu A, Zeiger R, Sorkness C, et al. Development and cross‐sectional validation of the childhood asthma control test. J Allergy Clin Immunol. 2007;119(4):817‐825.
Fonseca J, Nogueira‐Silva L, Morais‐Almeida M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010;65(8):1042‐1048.
Deschildre A, Pin I, El Abd K, et al. Asthma control assessment in a pediatric population: comparison between GINA/NAEPP guidelines, Childhood Asthma Control test (C‐ACT), and physician's rating. Allergy. 2014;69(6):784‐790.
Liu A, Zeiger R, Sorkness C, et al. The childhood asthma control test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. J Allergy Clin Immunol. 2010;126(2):267‐273.
Fidler A, Sweenie R, Ortega A, Cushing C, Ramsey R, Fedele D. Meta‐analysis of adherence promotion interventions in pediatric asthma. J Pediatr Psychol. 2021;46(10):1195‐1212.
Engelkes M, Janssens H, de Jongste J, Sturkenboom M, Verhamme K. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396‐407.
Gillette C, Rockich‐Winston N, Kuhn J, Flesher S, Shepherd M. Inhaler technique in children with asthma: a systematic review. Acad Pediatr. 2016;16(7):605‐616.
Liu W, Jiesisibieke Z, Tung T. Effect of asthma education on health outcomes in children: a systematic review. Arch Dis Child. 2022;107(12):1100‐1105.
Bender B. Nonadherence to asthma treatment: getting unstuck. J Allergy Clin Immunol Pract. 2016;4(5):849‐851.
Chan A, De Simoni A, Wileman V, et al. Digital interventions to improve adherence to maintenance medication in asthma. Cochrane Database Syst Rev. 2022;6(6):CD013030.
Stanojevic S, Kaminsky D, Miller M, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499.
Green R, Klein M, Becker P, et al. Disagreement among common measures of asthma control in children. Chest. 2013;143(1):117‐122.
Fuhlbrigge A, Kitch B, Paltiel A, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol. 2001;107(1):61‐67.
Fielding S, Pijnenburg M, de Jongste J, et al. Change in FEV1 and Feno measurements as predictors of future asthma outcomes in children. Chest. 2019;155(2):331‐341.
McGeachie M, Yates K, Zhou X, et al. Patterns of growth and decline in lung function in persistent childhood asthma. N Engl J Med. 2016;374(19):1842‐1852.
Boonjindasup W, Chang A, McElrea M, Yerkovich S, Marchant J. Does the routine use of spirometry improve clinical outcomes in children? – a systematic review. Pediatr Pulmonol. 2022;57(10):2390‐2397.
Yang Y, Lo D, Beardsmore C, et al. Implementing spirometry and fractional exhaled nitric oxide testing in childhood asthma management in UK primary care: an observational study to examine training and implementation cost and impact on patient's health use and outcome. Arch Dis Child. 2022;107(1):21‐25.
Khaleva E, Rattu A, Brightling C, et al. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA). Eur Respir J. 2023;61(4):2200606.
Gaillard E, Kuehni C, Turner S, et al. European Respiratory Society Clinical Practice Guidelines for the diagnosis of asthma in children aged 5‐16 years. Eur Respir J. 2021;58(5):2004173.
Nair S, Daigle K, DeCuir P, Lapin C, Schramm C. The influence of pulmonary function testing on the management of asthma in children. J Pediatr. 2005;147(6):797‐801.
Eid N, Yandell B, Howell L, Eddy M, Sheikh S. Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics. 2000;105(2):354‐358.
Pongracic J, Krouse R, Babineau D, et al. Distinguishing characteristics of difficult‐to‐control asthma in inner‐city children and adolescents. J Allergy Clin Immunol. 2016;138(4):1030‐1041.
Sharma S, Litonjua A, Tantisira K, et al. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol. 2008;122(5):921‐8.e4.
Grunwell J, Nguyen K, Bruce A, Fitzpatrick A. Bronchodilator dose responsiveness in children and adolescents: clinical features and association with future asthma exacerbations. J Allergy Clin Immunol Pract. 2020;8(3):953‐964.
Nève V, Matran R, Baquet G, et al. Quantification of shape of flow‐volume loop of healthy preschool children and preschool children with wheezing disorders. Pediatr Pulmonol. 2012;47(9):884‐894.
Beydon N, Nguyen T, Amsallem F, et al. Interrupter resistance to measure dose‐response to salbutamol in wheezy preschool children. Pediatr Pulmonol. 2018;53(9):1252‐1259.
Elenius V, Chawes B, Malmberg P, et al. Lung function testing and inflammation markers for wheezing preschool children: a systematic review for the EAACI Clinical Practice Recommendations on Diagnostics of Preschool Wheeze. Pediatr Allergy Immunol. 2021;32(3):501‐513.
King G, Bates J, Berger K, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55(2):1900753.
Kaminsky D, Simpson S, Berger K, et al. Clinical significance and applications of oscillometry. Eur Respir Rev. 2022;31(163):210208.
Grell A, Vera R, Yarur A, et al. Impulse oscillometry in preschool children with persistent asthma can predict spirometry at school age. Pediatr Pulmonol. 2023;58(5):1411‐1416.
Raywood E, Lum S, Aurora P, Pike K. The bronchodilator response in preschool children: a systematic review. Pediatr Pulmonol. 2016;51(11):1242‐1250.
Loke Y, Blanco P, Thavarajah M, Wilson A. Impact of inhaled corticosteroids on growth in children with asthma: systematic review and meta‐analysis. PLoS One. 2015;10(7):e0133428.
Chen W, Yang H, Hou C, et al. The influence of childhood asthma on adult height: evidence from the UK Biobank. BMC Med. 2022;20(1):94.
Zhang L, Lasmar L, Castro‐Rodriguez J. The impact of asthma and its treatment on growth: an evidence‐based review. J Pediatr (Rio J). 2019;95(Suppl 1):10‐22.
Rao R, Gregson R, Jones A, Miles E, Campbell M, Warner J. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. Eur Respir J. 1999;13(1):87‐94.
Salvatoni A, Piantanida E, Nosetti L, Nespoli L. Inhaled corticosteroids in childhood asthma: long‐term effects on growth and adrenocortical function. Paediatr Drugs. 2003;5(6):351‐361.
Leung J, Johnson D, Sperou A, et al. A systematic review of adverse drug events associated with administration of common asthma medications in children. PLoS One. 2017;12(8):e0182738.
Yao T, Huang Y, Chang S, Tsai S, Wu A, Tsai H. Association between Oral corticosteroid bursts and severe adverse events : a nationwide population‐based cohort study. Ann Intern Med. 2020;173(5):325‐330.
Sullivan P, Ghushchyan V, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110‐6.e7.
Volmer T, Effenberger T, Trautner C, Buhl R. Consequences of long‐term oral corticosteroid therapy and its side‐effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703.
Yao T, Wang J, Chang S, et al. Association of oral corticosteroid bursts with severe adverse events in children. JAMA Pediatr. 2021;175(7):723‐729.
Bourdin A, Adcock I, Berger P, et al. How can we minimise the use of regular oral corticosteroids in asthma? Eur Respir Rev. 2020;29(155):190085.
Petsky H, Kew K, Chang A. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016;11(11):CD011439.
Wang Z, Pianosi P, Keogh K, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management. 2017 https://www.ncbi.nlm.nih.gov/pubmed/29533572/
Lu M, Wu B, Che D, Qiao R, Gu H. FeNO and asthma treatment in children: a systematic review and meta‐analysis. Medicine. 2015;94(4):e347.
Ricciardolo F, Sorbello V, Ciprandi G. FeNO as biomarker for asthma phenotyping and management. Allergy Asthma Proc. 2015;36(1):e1‐e8.
Petsky H, Cates C, Lasserson T, et al. A systematic review and meta‐analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax. 2012;67(3):199‐208.
Harnan S, Tappenden P, Essat M, et al. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath. Health Technol Assess. 2015;19(82):1‐330.
Kamat S, Gouia I, Chao J, Small M, Khan A, Siddall J. Availability of fractional exhaled nitric oxide (FeNO) and eosinophil (EOS) count data among patients with severe asthma in five European countries. J Allergy Clin Immunol. 2020;145(2):AB205.
Anderson S. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine, and mannitol. Curr Opin Pulm Med. 2008;14(1):39‐45.
Kernen P, Steveling‐Klein E, Saccilotto R, et al. The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review. Swiss Med Wkly. 2019;149:w20100.
Nuijsink M, Hop W, Sterk P, Duiverman E, de Jongste J. Long‐term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J. 2007;30(3):457‐466.
Akar‐Ghibril N, Casale T, Custovic A, Phipatanakul W. Allergic endotypes and phenotypes of asthma. J Allergy Clin Immunol Pract. 2020;8(2):429‐440.
Kaiser S, Huynh T, Bacharier L, et al. Preventing exacerbations in preschoolers with recurrent wheeze: a meta‐analysis. Pediatrics. 2016;137(6):e20154496.
Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG, National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. Features of severe asthma in school‐age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol. 2006;118(6):1218‐1225.
Hartl S, Breyer M, Burghuber O, et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020;55(5):1901874.
Xepapadaki P, Adachi Y, Pozo Beltrán C, et al. Utility of biomarkers in the diagnosis and monitoring of asthmatic children. World Allergy Organ J. 2022;16(1):100727.
Levina D, Leontjeva M, Abbasova N, et al. Changes in blood eosinophil levels in early childhood and asthma development: a case‐control study. Pediatr Allergy Immunol. 2022;33(2):e13734.
Everhart R, Fiese B. Asthma severity and child quality of life in pediatric asthma: a systematic review. Patient Educ Couns. 2009;75(2):162‐168.
Halterman J, Yoos H, Conn K, et al. The impact of childhood asthma on parental quality of life. J Asthma. 2004;41(6):645‐653.
Goldbeck L, Koffmane K, Lecheler J, Thiessen K, Fegert J. Disease severity, mental health, and quality of life of children and adolescents with asthma. Pediatr Pulmonol. 2007;42(1):15‐22.
Gandhi P, Kenzik K, Thompson L, et al. Exploring factors influencing asthma control and asthma‐specific health‐related quality of life among children. Respir Res. 2013;14(1):26.
Wilson S, Rand C, Cabana M, et al. Asthma outcomes: quality of life. J Allergy Clin Immunol. 2012;129(3 Suppl):S88‐S123.
Mandhane P, McGhan S, Sharpe H, et al. A child's asthma quality of life rating does not significantly influence management of their asthma. Pediatr Pulmonol. 2010;45(2):141‐148.
Dudeney J, Sharpe L, Jaffe A, Jones E, Hunt C. Anxiety in youth with asthma: a meta‐analysis. Pediatr Pulmonol. 2017;52(9):1121‐1129.
Kulikova A, Lopez J, Antony A, et al. Multivariate Association of Child Depression and Anxiety with asthma outcomes. J Allergy Clin Immunol Pract. 2021;9(6):2399‐2405.
Fitzpatrick A, Mutic A, Mohammad A, Stephenson S, Grunwell J. Obesity is associated with sustained symptomatology and unique inflammatory features in children with asthma. J Allergy Clin Immunol Pract. 2022;10(3):815‐826.e2.
Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedón J. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127(3):741‐749.
Jensen M, Gibson P, Collins C, Hilton J, Wood L. Diet‐induced weight loss in obese children with asthma: a randomized controlled trial. Clin Exp Allergy. 2013;43(7):775‐784.
Friedlander J, Sheehan W, Baxi S, et al. Food allergy and increased asthma morbidity in a School‐based Inner‐City Asthma Study. J Allergy Clin Immunol Pract. 2013;1(5):479‐484.
Roberts G, Patel N, Levi‐Schaffer F, Habibi P, Lack G. Food allergy as a risk factor for life‐threatening asthma in childhood: a case‐controlled study. J Allergy Clin Immunol. 2003;112(1):168‐174.
Sova C, Feuling M, Baumler M, et al. Systematic review of nutrient intake and growth in children with multiple IgE‐mediated food allergies. Nutr Clin Pract. 2013;28(6):669‐675.
Skypala I, Reese I, Durban R, et al. Food allergy‐a holistic approach to dietary management. A joint EAACI Research & Outreach Committee and INDANA review. Pediatr Allergy Immunol. 2023;34(9):e14019.
Hansel N, Breysse P, McCormack M, et al. A longitudinal study of indoor nitrogen dioxide levels and respiratory symptoms in inner‐city children with asthma. Environ Health Perspect. 2008;116(10):1428‐1432.
Neophytou A, Oh S, White M, et al. Secondhand smoke exposure and asthma outcomes among African‐American and Latino children with asthma. Thorax. 2018;73(11):1041‐1048.
Orellano P, Quaranta N, Reynoso J, Balbi B, Vasquez J. Effect of outdoor air pollution on asthma exacerbations in children and adults: systematic review and multilevel meta‐analysis. PloS One. 2017;12(3):e0174050.
McConnell R, Berhane K, Gilliland F, et al. Asthma in exercising children exposed to ozone: a cohort study. Lancet. 2002;359(9304):386‐391.
Altman M, Kattan M, O'Connor G, et al. Associations between outdoor air pollutants and non‐viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis. Lancet Planet Health. 2023;7(1):e33‐e44.
Garcia E, Berhane K, Islam T, et al. Association of changes in air quality with incident asthma in children in California, 1993‐2014. JAMA. 2019;321(19):1906‐1915.
Rosenstreich D, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner‐city children with asthma. N Engl J Med. 1997;336(19):1356‐1363.
Grant T, Wood R. The influence of urban exposures and residence on childhood asthma. Pediatr Allergy Immunol. 2022;33(5):e13784.
Gergen P, Mitchell H, Calatroni A, et al. Sensitization and exposure to pets: the effect on asthma morbidity in the US population. J Allergy Clin Immunol Pract. 2018;6(1):101‐107.e2.
Zahradnik E, Raulf M. Animal allergens and their presence in the environment. Front Immunol. 2014;5:76.
Murray C, Foden P, Sumner H, Shepley E, Custovic A, Simpson A. Preventing severe asthma exacerbations in children. A randomized trial of mite‐impermeable bedcovers. Am J Respir Crit Care Med. 2017;196(2):150‐158.
Chapman MD, Wood RA. The role and remediation of animal allergens in allergic diseases. J Allergy Clin Immunol. 2001;107(3 Suppl):S414‐S421.
Behbod B, Sharma M, Baxi R, Roseby R, Webster P. Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke. Cochrane Database Syst Rev. 2018;1(1):CD001746.
Small S, Maddigan J, Swab M, Jarvis K. Pregnant and postnatal women's experiences of interacting with health care providers about their tobacco smoking: a qualitative systematic review. JBI Evid Synth. 2023;21(6):1066‐1189.
Marcolino M, Oliveira J, D'Agostino M, Ribeiro A, Alkmim M, Novillo‐Ortiz D. The impact of mHealth interventions: systematic review of systematic reviews. JMIR Mhealth Uhealth. 2018;6(1):e23.
Farzandipour M, Nabovati E, Sharif R, Arani M, Anvari S. Patient self‐Management of Asthma Using Mobile Health Applications: a systematic review of the functionalities and effects. Appl Clin Inform. 2017;8(4):1068‐1081.
Bousquet J, Shamji M, Anto J, et al. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach. Allergy. 2023;78:1758‐1776.
Lombardi C, Bonini M, Passalacqua G. The role of mobile apps in allergic respiratory diseases: an Italian multicentre survey report. Eur Ann Allergy Clin Immunol. 2018;50(6):268‐272.
Camacho‐Rivera M, Vo H, Huang X, Lau J, Lawal A, Kawaguchi A. Evaluating asthma Mobile apps to improve asthma self‐management: user ratings and sentiment analysis of publicly available apps. JMIR Mhealth Uhealth. 2020;8(10):e15076.
Dhruve H, Jackson D. Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices. Eur Respir Rev. 2022;31(164):210271.
Hoyte F, Mosnaim G, Rogers L, et al. Effectiveness of a digital inhaler system for patients with asthma: a 12‐week, open‐label, randomized study (CONNECT1). J Allergy Clin Immunol Pract. 2022;10(10):2579‐2587.
Mosnaim G, Safioti G, Brown R, et al. Digital health technology in asthma: a comprehensive scoping review. J Allergy Clin Immunol Pract. 2021;9(6):2377‐2398.
Ramsey R, Plevinsky J, Kollin S, Gibler R, Guilbert T, Hommel K. Systematic review of digital interventions for pediatric asthma management. J Allergy Clin Immunol Pract. 2020;8(4):1284‐1293.
Verhoeven E, Rouadi P, Jaoude E, et al. Digital tools in allergy and respiratory care. World Allergy Organ J. 2022;15(7):100661.
Bousquet J, Sousa‐Pinto B, Puggioni F, et al. Chapter 11 – Asthma in the digital world. In: Nadif R, ed. Asthma in the 21st century. Academic Press; 2023:231‐244.
Mortimer K, Reddel H, Pitrez P, Bateman E. Asthma management in low and middle income countries: case for change. Eur Respir J. 2022;60(3):2103179.